Dr. Fischer studies tissues from unique mouse models to elucidate the phenotypic progression involved in tumor formation. He received his Ph.D. in molecular genetics from the University of Cincinnati. Dr. Fischer is currently leading a research team at Oregon Health and Science University in partnership with Eternans to test the effects of Eternan’s senolytic agents on cancer in vivo.
Related Organizations
Articles from this author
September 17, 2025
[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...

